Cost-effectiveness Comparison of Ceftazidime/Avibactam Versus Meropenem in the Empirical Treatment of Hospital-acquired Pneumonia, Including Ventilator-associated Pneumonia, in Italy

Authors:

Abstract
No abstract available
Funding Information
  • Pfizer

This publication has 30 references indexed in Scilit: